American International Group’s Melinta Therapeutics, Inc. Common Stock MLNT Stock Holding History

American International Group’s Portfolio MLNT Stock Details MLNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-4,429	Closed	-$16K	–	3206
2019 Q1	$16K	Sell	4,429 -144	-3%	-$781	﹤0.01%	3009
2018 Q4	$18K	Sell	4,573 -35	-0.8%	-$448	﹤0.01%	3034
2018 Q3	$91K	Buy	4,608 +2,075	+82%	+$52.5K	﹤0.01%	2891
2018 Q2	$80K	Buy	2,533 +599	+31%	+$21.6K	﹤0.01%	2880
2018 Q1	$72K	Buy	1,934 +643	+50%	+$42.3K	﹤0.01%	2800
2017 Q4	$102K	Buy	+1,291	New	+$95.5K	﹤0.01%	2727

Other funds holding MLNT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

GIM

Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Sculptor Capital New York $9.61B AUM 27.49% 1-Year Est. Return

American International Group's MLNT Position: Q2 2019 in Review

American International Group sold out of Melinta Therapeutics, Inc. Common Stock (MLNT) in Q2 2019, closing a stake of 4,429 shares — an estimated $16K sold.

American International Group first reported a position in MLNT in Q4 2017 and held it in 6 quarters. The position peaked at $102K in Q4 2017. 53 funds tracked by Wall St. Rank hold MLNT as of Q2 2019.

American International Group reported no remaining Melinta Therapeutics, Inc. Common Stock position as of Q2 2019 after selling out during the quarter.
American International Group sold 4,429 Melinta Therapeutics, Inc. Common Stock shares in Q2 2019, an estimated $16K.
American International Group first reported a position in Melinta Therapeutics, Inc. Common Stock in Q4 2017 and held it in 6 quarters.
American International Group's Melinta Therapeutics, Inc. Common Stock position peaked at $102K in Q4 2017.
53 funds tracked by Wall St. Rank held Melinta Therapeutics, Inc. Common Stock as of Q2 2019.

Based on American International Group's 13F filing for Q2 2019, filed 13 Aug 2019.